Last 48 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 62.66 | 11.20 | 7.81 | 8.63 | — | 21.56 | 12.01 | 8.63 | 227.50 | 10.47 | 22.66 | 12.42 | 9.97 | 11.68 | 11.26 | 13.16 | — | 10.12 | 14.30 | 26.32 | 17.68 |
| — | -48.1% | -35.0% | -0.1% | — | +105.9% | -47.0% | -30.5% | +2180.8% | -10.3% | +101.3% | -5.7% | — | +15.4% | -21.2% | -50.0% | — | +1.8% | +27.7% | +14.1% | +12.6% | |
| P/S Ratio | 0.28 | 0.31 | 0.23 | 0.24 | 0.23 | 0.22 | 0.23 | 0.14 | 0.21 | 0.20 | 0.29 | 0.27 | 0.25 | 0.25 | 0.28 | 0.37 | 0.39 | 0.38 | 0.44 | 0.45 | 0.38 |
| — | +41.3% | +1.0% | +65.5% | +12.1% | +8.7% | -20.8% | -46.8% | -17.3% | -18.5% | +1.6% | -25.8% | -35.1% | -34.1% | -35.7% | -18.5% | +1.1% | -0.4% | +21.5% | +39.1% | +33.4% | |
| P/B Ratio | 1.47 | 1.66 | 1.18 | 1.34 | 1.31 | 1.13 | 1.11 | 0.75 | 1.05 | 0.99 | 1.36 | 1.33 | 1.21 | 1.22 | 1.34 | 1.71 | 1.77 | 1.62 | 1.81 | 1.83 | 1.51 |
| — | +47.1% | +6.5% | +79.9% | +24.1% | +14.1% | -18.5% | -43.9% | -12.8% | -18.8% | +1.7% | -22.2% | -31.6% | -24.8% | -26.1% | -6.3% | +16.8% | +7.7% | +29.7% | +41.7% | +36.0% | |
| P/FCF | 14.24 | 5.87 | 6.75 | 9.72 | 244.06 | 16.98 | 5.61 | 12.96 | — | 7.58 | 6.02 | — | 10.37 | 4.18 | 3.72 | — | 3.67 | 6.08 | 13.38 | 10.11 | 5.74 |
| — | -65.4% | +20.3% | -25.0% | — | +123.9% | -6.7% | — | — | +81.3% | +61.9% | — | +182.6% | -31.2% | -72.2% | — | -36.0% | +17.7% | +11.0% | +28.3% | -59.9% | |
| EV / EBITDA | 13.09 | 8.48 | 6.93 | 14.30 | — | 11.16 | 8.66 | 9.31 | 19.44 | 8.68 | 12.69 | 9.61 | 8.15 | 9.07 | 8.87 | 9.68 | — | 8.02 | 10.99 | 15.28 | 10.82 |
| — | -24.0% | -19.9% | +53.6% | — | +28.6% | -31.8% | -3.1% | +138.4% | -4.3% | +43.1% | -0.7% | — | +13.1% | -19.3% | -36.7% | — | -4.4% | +17.3% | +34.0% | +22.0% | |
| EV / EBIT | 18.89 | 10.44 | 8.52 | 21.77 | — | 16.45 | 11.52 | 11.37 | 45.21 | 11.87 | 18.84 | 12.76 | 10.58 | 12.08 | 11.38 | 12.34 | — | 9.79 | 14.07 | 23.46 | 16.53 |
| — | -36.5% | -26.0% | +91.5% | — | +38.6% | -38.9% | -10.9% | +327.3% | -1.7% | +65.6% | +3.4% | — | +23.4% | -19.2% | -47.4% | — | -6.6% | +15.9% | +6.9% | +8.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.8% | 14.8% | 15.6% | 12.8% | 13.4% | 13.7% | 15.2% | 13.2% | 13.2% | 14.7% | 14.2% | 14.8% | 15.1% | 15.3% | 15.7% | 16.5% | 16.5% | 17.2% | 17.4% | 17.8% | 17.2% |
| — | +8.0% | +2.2% | -2.8% | +2.0% | -6.3% | +7.2% | -10.7% | -13.0% | -4.1% | -9.4% | -10.2% | -8.3% | -11.0% | -10.0% | -7.6% | -4.1% | -5.4% | -3.6% | +3.7% | -1.5% | |
| Operating Margin | 2.6% | 4.4% | 4.7% | 2.0% | -3.1% | 2.4% | 3.6% | 2.4% | 0.9% | 3.3% | 2.6% | 3.6% | 4.1% | 3.6% | 4.0% | 4.3% | -4.8% | 5.8% | 4.6% | 2.9% | 4.1% |
| — | +84.2% | +30.6% | -17.5% | -457.6% | -27.9% | +38.9% | -32.6% | -78.8% | -8.2% | -36.5% | -16.7% | +185.1% | -37.2% | -12.4% | +48.3% | -216.4% | -2.8% | -10.9% | -19.8% | -14.4% | |
| Net Margin | 0.4% | 2.8% | 2.9% | 2.8% | -3.9% | 1.0% | 1.9% | 1.7% | 0.1% | 1.9% | 1.3% | 2.2% | 2.5% | 2.1% | 2.5% | 2.7% | -4.2% | 3.8% | 3.1% | 1.7% | 2.2% |
| — | +173.5% | +55.8% | +65.5% | -4337.0% | -46.8% | +49.4% | -22.9% | -96.4% | -9.3% | -49.8% | -20.6% | +160.0% | -43.1% | -18.3% | +61.0% | -293.8% | -2.0% | -4.8% | +21.9% | +18.6% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 2.3% | 3.8% | 3.8% | 4.0% | -5.3% | 1.3% | 2.3% | 2.2% | 0.1% | 2.4% | 1.5% | 2.7% | 3.1% | 2.6% | 3.0% | 3.2% | -4.6% | 4.0% | 3.1% | 1.7% | 2.2% |
| — | +188.0% | +65.2% | +81.8% | -4656.7% | -44.3% | +57.7% | -19.5% | -96.2% | -9.8% | -50.5% | -16.0% | +165.9% | -35.0% | -5.4% | +85.2% | -315.6% | +5.3% | -0.2% | +24.2% | +21.1% | |
| ROA | 0.7% | 1.2% | 1.1% | 1.1% | -1.5% | 0.4% | 0.7% | 0.7% | 0.0% | 0.7% | 0.4% | 0.8% | 0.9% | 0.8% | 0.9% | 1.0% | -1.5% | 1.3% | 1.0% | 0.6% | 0.7% |
| — | +197.5% | +63.7% | +75.3% | -4586.1% | -43.6% | +56.9% | -20.4% | -96.2% | -9.3% | -51.2% | -18.5% | +161.1% | -40.6% | -9.6% | +79.5% | -315.2% | +8.3% | +4.6% | +33.0% | +31.2% | |
| ROIC | 5.0% | 2.4% | 2.3% | 1.0% | -1.6% | 1.2% | 1.7% | 1.2% | 0.4% | 1.6% | 1.2% | 1.7% | 2.0% | 1.8% | 2.0% | 2.1% | -2.2% | 2.5% | 1.9% | 1.2% | 1.6% |
| — | +101.2% | +34.8% | -12.3% | -489.6% | -22.9% | +46.4% | -32.5% | -78.5% | -11.6% | -41.0% | -18.0% | +187.4% | -29.6% | +4.8% | +82.1% | -241.3% | +13.7% | +3.0% | -9.0% | -4.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.24 | 0.96 | 1.01 | 1.24 | 1.12 | 1.07 | 1.05 | 1.09 | 1.10 | 1.12 | 1.10 | 1.04 | 1.07 | 1.13 | 1.07 | 0.99 | 1.00 | 0.98 | 1.02 | 1.01 | 1.05 |
| — | -10.5% | -4.2% | +13.4% | +1.5% | -4.4% | -4.5% | +5.7% | +2.4% | -0.8% | +3.2% | +5.1% | +7.4% | +14.5% | +4.3% | -2.2% | -5.1% | -9.3% | -11.5% | -17.4% | -16.5% | |
| Debt / EBITDA | 6.24 | 13.09 | 13.52 | 28.72 | — | 23.29 | 17.94 | 23.59 | 41.50 | 19.98 | 23.99 | 17.61 | 16.63 | 18.93 | 17.20 | 15.16 | — | 12.90 | 16.52 | 22.73 | 18.75 |
| — | -43.8% | -24.6% | +21.7% | — | +16.6% | -25.2% | +33.9% | +149.6% | +5.5% | +39.5% | +16.2% | — | +46.8% | +4.1% | -33.3% | — | -11.5% | -5.6% | -2.1% | -6.3% | |
| Current Ratio | 0.84 | 0.87 | 0.87 | 0.84 | 0.83 | 0.80 | 0.82 | 0.81 | 0.80 | 0.86 | 0.81 | 0.86 | 0.86 | 0.86 | 0.92 | 0.95 | 0.94 | 0.91 | 0.88 | 0.88 | 0.94 |
| — | +7.7% | +5.2% | +3.8% | +4.5% | -6.5% | +1.6% | -5.3% | -7.5% | +0.5% | -11.5% | -9.4% | -8.9% | -5.8% | +3.9% | +6.8% | +0.4% | -4.8% | -5.0% | -2.6% | -1.5% | |
| Quick Ratio | 0.63 | 0.66 | 0.66 | 0.63 | 0.63 | 0.62 | 0.63 | 0.60 | 0.59 | 0.66 | 0.61 | 0.63 | 0.64 | 0.64 | 0.67 | 0.67 | 0.69 | 0.65 | 0.62 | 0.62 | 0.67 |
| — | +7.3% | +5.2% | +4.7% | +6.8% | -6.6% | +2.2% | -5.1% | -8.2% | +3.9% | -8.7% | -6.1% | -7.8% | -2.6% | +8.3% | +7.6% | +3.4% | -2.0% | -2.1% | +2.0% | -0.2% | |
| Interest Coverage | 1.68 | 6.25 | 6.09 | 2.72 | -3.44 | 3.16 | 4.33 | 3.80 | 1.14 | 4.19 | 3.21 | 4.92 | 5.36 | 4.75 | 5.89 | 6.63 | -6.85 | 8.08 | 6.12 | 3.58 | 4.56 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CVS stock.
CVS Health Corp.'s current P/E is 62.7x. The average P/E over the last 3 quarters is 9.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
CVS Health Corp.'s current operating margin is 2.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking CVS Health Corp.'s business trajectory between earnings reports.